Our findings provide novel insight into the mechanism of the ameliorating effect of DMTS on depression and anxiety and suggest that TRPA1 is a promising therapeutic target for mood disorders, which exploits new paths for the prevention and cure of depression under chronic stress. Here, TRPA1 is linked to major depressive disorder.